Melola Discovery

← Melola Discovery

Open access Journal SINTA 1

The Role of The Chronic Disease Management Program in Indonesia (PROLANIS) As A Diabetes Mellitus Management Strategy: A Scoping Review

Public Health of Indonesia · Vol. 10 No. 2 (2024) · pp. 247–261

DOI
10.36685/phi.v10i2.753
ISSN
2477-1570, 2528-1542
Published
2024-06-25
Publisher
YCAB Publisher
Language
eng
License
creativecommons.org/licenses/by-nc/4.0

Abstract

Background:Diabetes Mellitus (DM) is a non-communicable disease with an increasing number of sufferers every year, and its negative impacts require special attention. The Indonesian government has taken steps to manage DM by establishing the PROLANIS program. Objective:This study aims to identify the roles of PROLANIS in treating DM in Indonesia. Methods:This study used a scoping review design. We performed extensive searches in CINAHL Plus, Cochrane Library, Embase, PubMed, and Google Scholar. Based on the search results, we found a total of 280 articles. After a selection process, 27 articles met the criteria for review. The papers were grouped by year, study design, setting, and the role of PROLANIS. Results:According to research results, PROLANIS effectively maintains and reduces several essential aspects of DM patients' health, such as body mass index, fasting blood glucose, and HbA1c levels. PROLANIS also plays a positive role in improving the lipid profiles of DM patients. Furthermore, PROLANIS contributes to increasing self-efficacy, self-acceptance, self-management, adherence to therapy, and overall quality of life. Conclusion:PROLANIS positively affects the management of DM by improving physical health and enhancing the quality of life for patients. Keywords:chronic disease; Diabetes Mellitus; non-communicable diseases; PROLANIS

Keywords

Collaboration network of the authors

30 authors · 87 co-authorship links · 50 across different organisations

Hover or tap a name to highlight its co-authors. Double-click to open the author's page.

  • Universitas Respati Yogyakarta
  • National Taipei University of Nursing and Health Science
  • Universitas Muhammadiyah Semarang
  • Universitas Nahdlatul Ulama Surabaya
  • Politeknik Kesehatan Kemenkes Semarang
  • State University of Semarang
  • Universitas 'Aisyiyah Yogyakarta
  • Other organisations
  • Affiliation unknown
  • Different organisations
  • Same organisation
  • Affiliation unknown
  • Thicker line = more joint articles · bigger circle = more articles
Show as table
Co-authorOrganisationJoint articles
Santi DamayantiUniversitas Respati Yogyakarta3
Nazwar Hamdani RahilUniversitas Respati Yogyakarta2
Sri SahayatiUniversitas Respati Yogyakarta2
Agus SuhartoMuhammadiyah University of Yogyakarta2
Sugiyarto SugiyartoPoliteknik Kesehatan Kemenkes Surakarta2
Herry SusantoSultan Agung Islamic University2
Adi SuciptoUniversitas Respati Yogyakarta1
Sumarni SumarniPoliteknik Kesehatan Kemenkes Semarang1
Uswatun KhasanahState University of Semarang1
Ariyanto NugrohoUniversitas Respati Yogyakarta1
Fika Lilik IndrawatiNational Taipei University of Nursing and Health Science1
Ariyanto NughrohoUniversitas 'Aisyiyah Yogyakarta1
Muflih MuflihUniversitas Respati Yogyakarta1
Merita Eka RahmuniyatiUniversitas Respati Yogyakarta1
Yelli Yani RusyaniUniversitas Respati Yogyakarta1
Ani FaridaUniversitas Respati Yogyakarta1
Ara’ Afliyatun Nur SariUniversitas Respati Yogyakarta1
Hidayat ArifinUniversitas Airlangga1
Sirikanok KlankhajhonNaresuan University1
Shu-Fang Vivienne WuAffiliation unknown1
Shu-Yuan LiangNational Taipei University of Nursing and Health Science1
Satriya PranataUniversitas Muhammadiyah Semarang1
Yeu‐Hui ChuangTaipei Medical University1
Kuo‐Cheng LuFu Jen Catholic University1
Tsae-Jyy Tiffany WangNational Taipei University of Nursing and Health Science1
Aric VranadaUniversitas Muhammadiyah Semarang1
Merita Eka RahmuniatiAffiliation unknown1

Affiliations come from OpenAlex; journal OAI-PMH metadata carries none. Authors without an OpenAlex ID are matched by name, which can merge or split people.

Metadata source: OAI-PMH (metadata jurnal) http://stikbar.org/ycabpublisher/index.php/PHI/oai, first harvested 10 Nov 2026, last seen 16 Nov 2026.
Original metadata (oai_dc)
<oai_dc:dc xmlns="http://www.openarchives.org/OAI/2.0/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:oai_dc="http://www.openarchives.org/OAI/2.0/oai_dc/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/oai_dc/  http://www.openarchives.org/OAI/2.0/oai_dc.xsd">
	<dc:title xml:lang="en-US">The Role of The Chronic Disease Management Program in Indonesia (PROLANIS) As A Diabetes Mellitus Management Strategy: A Scoping Review</dc:title>
	<dc:creator>Fadlilah, Siti</dc:creator>
	<dc:creator>Nugroho, Ariyanto</dc:creator>
	<dc:creator>Bistara, Difran Nobel</dc:creator>
	<dc:subject xml:lang="en-US">chronic disease; Diabetes Mellitus; noncommunicable diseases; PROLANIS</dc:subject>
	<dc:description xml:lang="en-US">Background:Diabetes Mellitus (DM) is a non-communicable disease with an increasing number of sufferers every year, and its negative impacts require special attention. The Indonesian government has taken steps to manage DM by establishing the PROLANIS program.
Objective:This study aims to identify the roles of PROLANIS in treating DM in Indonesia.
Methods:This study used a scoping review design. We performed extensive searches in CINAHL Plus, Cochrane Library, Embase, PubMed, and Google Scholar. Based on the search results, we found a total of 280 articles. After a selection process, 27 articles met the criteria for review. The papers were grouped by year, study design, setting, and the role of PROLANIS.
Results:According to research results, PROLANIS effectively maintains and reduces several essential aspects of DM patients' health, such as body mass index, fasting blood glucose, and HbA1c levels. PROLANIS also plays a positive role in improving the lipid profiles of DM patients. Furthermore, PROLANIS contributes to increasing self-efficacy, self-acceptance, self-management, adherence to therapy, and overall quality of life.
Conclusion:PROLANIS positively affects the management of DM by improving physical health and enhancing the quality of life for patients.
Keywords:chronic disease; Diabetes Mellitus; non-communicable diseases; PROLANIS</dc:description>
	<dc:publisher xml:lang="en-US">YCAB Publisher</dc:publisher>
	<dc:date>2024-06-25</dc:date>
	<dc:type>info:eu-repo/semantics/article</dc:type>
	<dc:type>info:eu-repo/semantics/publishedVersion</dc:type>
	<dc:type xml:lang="en-US">Peer-reviewed Article</dc:type>
	<dc:format>application/pdf</dc:format>
	<dc:identifier>https://stikbar.org/ycabpublisher/index.php/PHI/article/view/753</dc:identifier>
	<dc:identifier>10.36685/phi.v10i2.753</dc:identifier>
	<dc:source xml:lang="en-US">Public Health of Indonesia; Vol. 10 No. 2 (2024): April - June; 247-261</dc:source>
	<dc:source>2477-1570</dc:source>
	<dc:source>2528-1542</dc:source>
	<dc:source>10.36685/phi.v10i2</dc:source>
	<dc:language>eng</dc:language>
	<dc:relation>https://stikbar.org/ycabpublisher/index.php/PHI/article/view/753/326</dc:relation>
	<dc:rights xml:lang="en-US">Copyright (c) 2024 Siti Fadlilah, Ariyanto Nugroho, Difran Nobel Bistara</dc:rights>
	<dc:rights xml:lang="en-US">https://creativecommons.org/licenses/by-nc/4.0</dc:rights>
</oai_dc:dc>